Cargando…

Current and Future Treatments for Diabetic Retinopathy

Detalles Bibliográficos
Autores principales: Behar-Cohen, Francine, Loewenstein, Anat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026793/
https://www.ncbi.nlm.nih.gov/pubmed/35456647
http://dx.doi.org/10.3390/pharmaceutics14040812
_version_ 1784691199967232000
author Behar-Cohen, Francine
Loewenstein, Anat
author_facet Behar-Cohen, Francine
Loewenstein, Anat
author_sort Behar-Cohen, Francine
collection PubMed
description
format Online
Article
Text
id pubmed-9026793
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90267932022-04-23 Current and Future Treatments for Diabetic Retinopathy Behar-Cohen, Francine Loewenstein, Anat Pharmaceutics Editorial MDPI 2022-04-07 /pmc/articles/PMC9026793/ /pubmed/35456647 http://dx.doi.org/10.3390/pharmaceutics14040812 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Behar-Cohen, Francine
Loewenstein, Anat
Current and Future Treatments for Diabetic Retinopathy
title Current and Future Treatments for Diabetic Retinopathy
title_full Current and Future Treatments for Diabetic Retinopathy
title_fullStr Current and Future Treatments for Diabetic Retinopathy
title_full_unstemmed Current and Future Treatments for Diabetic Retinopathy
title_short Current and Future Treatments for Diabetic Retinopathy
title_sort current and future treatments for diabetic retinopathy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026793/
https://www.ncbi.nlm.nih.gov/pubmed/35456647
http://dx.doi.org/10.3390/pharmaceutics14040812
work_keys_str_mv AT beharcohenfrancine currentandfuturetreatmentsfordiabeticretinopathy
AT loewensteinanat currentandfuturetreatmentsfordiabeticretinopathy